A

AprilBio Co Ltd
KOSDAQ:397030

Watchlist Manager
AprilBio Co Ltd
KOSDAQ:397030
Watchlist
Price: 43 400 KRW 2.72%
Market Cap: 989.5B KRW

Net Margin
AprilBio Co Ltd

10.7%
Current
-800%
Average
-6.4%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
10.7%
=
Net Income
959.4m
/
Revenue
9B

Net Margin Across Competitors

No Stocks Found

AprilBio Co Ltd
Glance View

Market Cap
977.7B KRW
Industry
Biotechnology

AprilBio Co Ltd is a Korea-based company primarily engaged in the biological drug development business. The Company is primarily engaged in the bio-innovative new drug research and development (R&D) business such as antibody therapeutics and long-acting recombinant protein pharmaceuticals.

Intrinsic Value
19 101.15 KRW
Overvaluation 56%
Intrinsic Value
Price
A
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
10.7%
=
Net Income
959.4m
/
Revenue
9B
What is the Net Margin of AprilBio Co Ltd?

Based on AprilBio Co Ltd's most recent financial statements, the company has Net Margin of 10.7%.

Back to Top